
DANAHER CORP
DHRNYSETrading Snapshot
- Day Range
- $206.33 β $209.45
- 52-Week Range
- $160.93 β $242.80
- Volume
- $2.33B
- Avg Volume
- $1.64B
- Shares Outstanding
- 703.0M
- Next Earnings
- Sep 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $24.57B
- Last Q Revenue
- $6.26B
- P/E Ratio
- 36.2
- P/S Ratio
- 5.8x
- EPS (TTM)
- $5.63
- Dividend Yield
- 0.67%
Why Investors Own DHR
- βHigh-growth profile β revenue up +5.7% YoY with expanding US Equity exposure.
- βHealthy economics β 68% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About DANAHER CORP
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water typesβincluding ultra-pure, potable, industrial, waste, ground, source, and ocean waterβacross residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
DANAHER CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift DHR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
DANAHER CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.